Biotech News

Sanofi: Information concerning the total number of voting rights and shares - August 2026

Sanofi (SNY)SanofiCommercial

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority)

Sanofi a French société anonyme with a registered share capital of €2,415,546,786 Registered office : 46, avenue de la Grande Armée - 75017 Paris - France Registered at the Paris Commercial and Companies Registry under number 395 030 844

DateTotal number of issued sharesNumber of real voting rights (excluding treasury shares)Theoretical number of voting rights (including treasury shares)*
August 31, 20261,207,773,3931,336,151,9331,343,318,995

* Pursuant to Article 223-11 of the Règlement général de l’Autorité des Marchés Financiers.

This information is also available on the internet website of sanofi:

https://www.sanofi.com/en/investors/sanofi-share-and-adrs/shares-structure-vote

EN_number_of_voting_rights_and_shares_August_2026

Related news

Sanofi

Sanofi is a global healthcare company with meaningful exposure to immunology, vaccines, rare disease, and consumer health. The company has been building a more focused innovation story while maintaining a broad global base.

Recent company news

Stock data

Close
39.56 USD
Market cap
102.45B USD
Exchange
NASDAQ
Sector
Generics, Antibody Drugs, CNS, Gene Therapy, Novel Therapies, Biopharma, Vaccines
Location
United States